康臣药业(01681.HK)11月18日耗资441.7万港元回购30万股

Core Viewpoint - 康臣药业 announced a share buyback of 300,000 shares at a cost of HKD 4.417 million on November 18 [1] Company Summary - 康臣药业 executed a buyback program, indicating a commitment to enhancing shareholder value through repurchasing shares [1] - The total expenditure for the buyback was HKD 4.417 million, reflecting the company's strategy to manage its capital structure [1]